GGrantIndex
← Leaderboards

Tejal A. Desai

Boston University

$14,922,918
Attributed
$19,593,574
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.9M · FY201025
$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$19,593,574 · 10

By mechanism

R01$9,375,227 · 5
T32$7,914,321 · 2
U54$1,707,714 · 1
R21$596,312 · 2

Top collaborators

Others in their field

Top investigators on “In Vitro

Research focus

In VitroDrug Delivery SystemsCellsStructureMechanicsEngineeringPharmaceutical PreparationsSurfaceDesignIn VivoProteinsMorphologyMediatingTight JunctionsNanostructuresDoseMacromoleculePermeabilityResponseAffectAnimalsBiomedical EngineeringJointsEpithelium

Grant awards (35)

Regulation of epithelial function using targeted nanowires$612,502
R01 · FY2025 · HL
Regulation of epithelial function using targeted nanowires$600,252
R01 · FY2024 · HL
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.$805,361
R01 · FY2023 · AI
Regulation of epithelial function using targeted nanowires$612,502
R01 · FY2023 · HL
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.$809,270
R01 · FY2022 · AI
Regulation of epithelial function using targeted nanowires$631,322
R01 · FY2022 · HL
UCSF/UCB Joint Graduate Group in Bioengineering$877,732
T32 · FY2021 · GM · contact PI
ACE2-targeted PET radiotracers for investigating spatiotemporal distribution of SARS-CoV-2 organ injury and therapy response.$828,473
R01 · FY2021 · AI
Microstructural Cues for the Treatment of Heart Failure$399,737
R01 · FY2021 · HL · contact PI
UCSF/UCB Joint Graduate Group in Bioengineering$814,296
T32 · FY2020 · GM · contact PI
Microstructural Cues for the Treatment of Heart Failure$397,590
R01 · FY2020 · HL · contact PI
User-control and safety$1,707,714
U54 · FY2019 · CA · contact PI
UCSF/UCB Joint Graduate Group in Bioengineering$810,242
T32 · FY2019 · GM · contact PI
Microstructural Cues for the Treatment of Heart Failure$395,177
R01 · FY2019 · HL · contact PI
UCSF/UCB Joint Graduate Group in Bioengineering$801,209
T32 · FY2018 · GM · contact PI
Microstructural Cues for the Treatment of Heart Failure$393,300
R01 · FY2018 · HL · contact PI
UCSF/UCB Joint Graduate Group in Bioengineering$699,173
T32 · FY2017 · GM · contact PI
Mechanisms of nanostructure-enhanced transepithelial drug delivery$349,571
R01 · FY2017 · EB · contact PI
UCSF/UCB Joint Graduate Group in Bioengineering$691,591
T32 · FY2016 · GM · contact PI
Mechanisms of nanostructure-enhanced transepithelial drug delivery$349,722
R01 · FY2016 · EB · contact PI
UCSF/UCB Joint Graduate Group in BIoengineering$638,771
T32 · FY2015 · GM · contact PI
Mechanisms of nanostructure-enhanced transepithelial drug delivery$342,812
R01 · FY2015 · EB · contact PI
UCSF/UCB Joint Graduate Group in BIoengineering$652,471
T32 · FY2014 · GM · contact PI
Nanoporous Films for Ocular Drug Delivery$371,678
R01 · FY2014 · EY · contact PI
Mechanisms of nanostructure-enhanced transepithelial drug delivery$357,130
R01 · FY2014 · EB · contact PI
UCSF/UCB Joint Graduate Group in BIoengineering$645,278
T32 · FY2013 · GM · contact PI
Nanoporous Films for Ocular Drug Delivery$360,300
R01 · FY2013 · EY · contact PI
UCSF/UCB Joint Graduate Group in BIoengineering$645,278
T32 · FY2012 · GM · contact PI
Nanoporous Films for Ocular Drug Delivery$379,264
R01 · FY2012 · EY · contact PI
UCSF/UCB Joint Graduate Group in BIoengineering$638,280
T32 · FY2011 · GM · contact PI
Nanoporous Films for Ocular Drug Delivery$379,264
R01 · FY2011 · EY · contact PI
Engineering Particle Nanostructure for Enhanced Bioadhesion$216,597
R21 · FY2011 · EB · contact PI
Engineering Particle Nanostructure for Enhanced Bioadhesion$186,715
R21 · FY2010 · EB · contact PI
NANOPOROUS INOGANIC BIOCAPSULES$90,375
R21 · FY2003 · EB
NANOPOROUS INOGANIC BIOCAPSULES$102,625
R21 · FY2002 · EB